Compounding Crisis: Johnson Fistel's Probe into Hims & Hers' Semaglutide Scandal

San Diego, California--(Newsfile Corp. - June 24, 2025) - Johnson Fistel, PLLP announces that it is investigating potential claims on behalf of investors of Hims & Hers Health, Inc. (NYSE: HIMS) regarding possible violations of federal securities laws. Investors who purchased Hims & Hers securities may be eligible to recover losses stemming from alleged misrepresentations and omissions made by the company and its executives.

What if I purchased Hims & Hers securities? If you incurred significant losses and want to determine if you are eligible to participate in the potential class action or to seek a recovery of your losses, follow the link provided:
https://www.johnsonfistel.com/investigations/hims-hers-health-inc

For more information, contact James Baker at (619) 814-4471, jimb@johnsonfistel.com or fjohnson@johnsonfistel.com.

On June 23, 2025, Novo Nordisk terminated its collaboration with Hims & Hers Health, citing serious concerns over the company's sale of compounded medications marketed as personalized treatments. According to Novo Nordisk, Hims allegedly skirted regulations by mass-distributing semaglutide-based drugs that may contain unauthorized foreign substances, raising significant safety red flags. This development has prompted increased scrutiny of Hims' business practices and legal compliance.

About Johnson Fistel, PLLP | Top Law Firm, Securities Fraud, Investors Rights:
Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. We also extend our services to foreign investors who have purchased on US exchanges. Stay updated with news on stock drops and learn how Johnson Fistel, PLLP can help you recover your losses. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com.

Achievements:
In 2024, Johnson Fistel was honored to be ranked in the Top 10 Plaintiff Law Firms by the ISS Securities Class Action Services. This recognition underscores our effectiveness in advocating for investors, having recovered approximately $90,725,000 for aggrieved clients in cases where we served as lead or co-lead counsel. This notable accomplishment marks the eighth occasion our firm has been recognized as a top plaintiffs' securities law firm in the United States, as determined by the total dollar value of final recoveries.

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/256630